Photo taken from Janice Mehnert/X
Feb 4, 2024, 18:00
Janice Mehnert: Adjuvant therapy appears to benefit patients with acral, but not mucosal, melanoma
Janice Mehnert, Associate Director For Clinical Research at
“First paper of 2024! In a retrospective analysis, adjuvant therapy appears to benefit patients with acral, but not mucosal, melanoma. Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based th…”
Source: Janice Mehnert/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 15:20
Nov 21, 2024, 14:56
Nov 21, 2024, 14:41
Nov 21, 2024, 13:55
Nov 21, 2024, 13:46
Nov 21, 2024, 13:25
Nov 21, 2024, 12:57